Despite ever-growing experimental evidence for the utility of a wide range of tumour
markers, only a handful are understood to be useful in clinical applications. Tumour markers …

This integrated book covers the entire spectrum of cancer biomarkers in development and
clinical use. Predictive and prognostic markers are explored in the context of colon cancer …

The overall goal in caring for a patient with any disease is to provide benefit and minimise
toxicity. Given the nature of anti-neoplastic therapies, this goal is especially important in the …

Tumor markers include a wide spectrum of biomolecules produced by a wide variety of
tumors or the body in response to the tumor. They play a significant role in screening …

This unique synthesis of chapters from top experts in their fields targets the essential area of
cancer biomarkers and the need for better and more rigorous design and clinical trials. The …

The potential of molecular markers to significantly improve early detection of localized
cancers provides an unprecedented opportunity to understand the biology, improve …

Testing for tumour markers should only be performed if it results in a better patient outcome,
increased quality of life or reduced overall cost of care. Ideally, the clinical value of a tumour …

It has well reported that tumor markers have many advantages like minimally invasive,
convenient use, low cost but also has many limitations like low sensitivity and specificity …

The history of tumor biomarker discovery has been one of limited success. Population based
screens are few and of limited clinical usefulness. Biomarkers that are able to segregate …

Biomarkers play a key role in the diagnosis and management of patients with cancer, and
are important for fulfilling the promise of precision medicine in oncology. However, although …